Andrés Cervantes is a leading European medical oncologist and cancer policy advocate. He is the Scientific Director of the INCLIVA Health Research Institute, Head of the Medical Oncology Department at Hospital Clínico Universitario de Valencia, and Professor of Medicine at the University of Valencia.
Dr. Cervantes has served as President of the European Society for Medical Oncology (ESMO), one of the world’s foremost oncology societies, representing nearly 30,000 oncology professionals globally. As ESMO President, Dr. Cervantes focused on equitable access to cancer diagnosis and treatment, strengthening education for young oncologists, and expanding ESMO’s global footprint, particularly in low- and middle-income countries. His leadership aligned closely with Europe’s Beating Cancer Plan, emphasizing prevention, early detection, high-quality care, and survivorship support.
A strong advocate for a holistic approach to cancer, Dr. Cervantes highlights not only scientific and clinical progress but also the social impact of cancer, particularly the needs of Europe’s growing population of cancer survivors. His work reflects a lifelong commitment to integrating research, education, and patient care as a service to society, with the goal of reducing disparities and improving outcomes across Europe and beyond.
The 100 Most Influential People in Oncology in 2025 recognizes the changemakers in cancer care who have helped shape current practice in oncology and continue to drive innovation and research towards better outcomes, advocacy, philanthropy, leadership, and education. For the many deserving individuals not mentioned in this list, we will continue to acknowledge, honor, and elevate your voices in our daily publications from across the world.
See the full list of The 100 Influential People in Oncology in 2025 and stay tuned for the results of special category nominations to be announced.
